XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash Flows from Operating Activities    
Net income $ 2,065 $ 2,059
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation, amortization and accretion, net (11) 95
Deferred income tax expense (benefit) 177 63
Share-based compensation 127 124
Net realized investment (gains) losses (5) (627)
Net trading (gains) losses 8 3
Loss from equity method investments 25 58
Impairments and provision for loan and credit losses 93 2
Net (gains) losses of consolidated investment entities 5 (17)
Changes in operating assets and liabilities:    
Restricted and segregated investments (246) (101)
Deferred acquisition costs 204 (128)
Policyholder account balances, future policy benefits and claims, net 754 1,174
Derivatives, net of collateral 465 (290)
Receivables (132) (360)
Brokerage deposits (168) (45)
Accounts payable and accrued expenses (414) 146
Current income tax, net (61) (393)
Deferred taxes, net 10 (112)
Other operating assets and liabilities of consolidated investment entities, net 1 15
Other, net 293 108
Net cash provided by (used in) operating activities 3,190 1,774
Available-for-Sale securities:    
Proceeds from sales 738 555
Maturities, sinking fund payments and calls 5,849 8,992
Purchases (15,452) (10,047)
Proceeds from sales, maturities and repayments of mortgage loans 111 242
Funding of mortgage loans (147) (166)
Proceeds from sales, maturities and collections of other investments 48 155
Purchase of other investments (75) (73)
Purchase of investments by consolidated investment entities (763) (1,461)
Proceeds from sales, maturities and repayments of investments by consolidated investment entities 466 850
Purchase of land, buildings, equipment and software (126) (86)
Cash paid for written options with deferred premiums (411) (314)
Cash received from written options with deferred premiums 141 60
Cash returned (paid) for acquisition of business, net of cash acquired 34 0
Cash paid for deposit receivables (34) (216)
Cash received for deposit receivables 393 132
Other, net (13) 4
Net cash provided by (used in) investing activities (9,241) (1,373)
Investment certificates:    
Proceeds from additions 3,844 2,004
Maturities, withdrawals and cash surrenders (2,942) (3,320)
Policyholder account balances:    
Deposits and other additions 766 1,131
Net transfers from (to) separate accounts (128) (206)
Surrenders and other benefits (989) (1,002)
Change in banking deposits, net 7,173 2,412
Cash paid for purchased options with deferred premiums (159) (94)
Cash received from purchased options with deferred premiums 230 580
Issuance of long-term debt 495 4
Repayments of long-term debt (507) (6)
Dividends paid to shareholders (401) (384)
Repurchase of common shares (1,490) (1,467)
Borrowings of consolidated investment entities 341 1,375
Repayments of debt by consolidated investment entities (1) (757)
Other, net (19) (11)
Net cash provided by (used in) financing activities 6,213 259
Effect of exchange rate changes on cash (116) (9)
Net increase (decrease) in cash and cash equivalents, including amounts restricted 46 651
Cash and cash equivalents, including amounts restricted, at beginning of period 9,569 8,903
Cash and cash equivalents, including amounts restricted, at end of period 9,615 9,554
Supplemental Disclosures:    
Income taxes paid, net 367 867
Leased assets obtained in exchange for operating lease liabilities 42 63
Non-cash investing activity:    
Investments transferred in connection with reinsurance transaction 0 7,527
Exchange of an investment that resulted in a realized gain and an increase to amortized cost 0 17
Reconciliation of cash and cash equivalents, including amounts restricted:    
Restricted and segregated cash, cash equivalents and investments 2,343  
Less: Restricted and segregated investments (721)  
Total cash and cash equivalents including amounts restricted 9,615 9,554
Ameriprise Financial    
Supplemental Disclosures:    
Interest paid 89 85
Reconciliation of cash and cash equivalents, including amounts restricted:    
Cash and cash equivalents 7,819  
Consolidated investment entities    
Supplemental Disclosures:    
Interest paid 49 $ 73
Reconciliation of cash and cash equivalents, including amounts restricted:    
Cash and cash equivalents $ 174